|Slideshows|February 28, 2020

Vol 37, Issue 2
Volume 37
Issue 2

In This Issue of Psychiatric Times: Vol 37, No 2

Author(s)Laurie Martin

Read the Psychiatric Times February 2020 issue cover-to-cover, with a bonus PDF.

Articles in this issue

over 5 years ago

Article

Chaos Theory With a Human Face: Niall McLaren, MBBS, FRANZCP

over 5 years ago

Article

Introduction: Trauma and Its Psychiatric Consequences

over 5 years ago

Article

Violent Behavior and Involuntary Commitment: Ethical and Clinical Considerations

over 5 years ago

Article

Pharmacological Management of Violence and Violent Behavior in Psychiatric Settings

over 5 years ago

Article

Stroke in Young Adults: The Lasting Effects of Trauma

over 5 years ago

Article

The Non-Binary Story and the Rescue of Self: Healing Stories of the Third Kind

over 5 years ago

Article

The Show Must Go On

over 5 years ago

Article

Psychiatric Malpractice Grand Rounds: Addiction Psychiatry

over 5 years ago

Article

The Arms of Ivy Welcome Her

over 5 years ago

Article

Bipolar Disorder: Practice-Changing Trials from 2019

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

“Porosity”: Connecting 2 Western Cultural Psychiatric Discourses in Tokyo by Way of Naples

ByVincenzo Di Nicola, MPhil, MD, PhD, FCAHS, DLFAPA, DFCPA, FACPsych, FRSC

October 29th 2025

Social Determinants of Health and Mental Health: Concepts and Practice of Growing Relevance

ByRenato D. Alarcón, MD, MPH,Dilip V. Jeste, MD

October 16th 2025

The Psychiatric Lens on Extraordinary Experiences: Improving Care Without Misdiagnosis

ByMarina Weiler, PhD,Marieta Pehlivanova, PhD,Philip J. Cozzolino, PhD,J. Kim Penberthy, PhD, ABPP

September 29th 2025

Social Psychiatry and Culturally Relevant Psychotherapy at the APA Annual Meeting

ByLeah Kuntz,Vincenzo Di Nicola, MPhil, MD, PhD, FCAHS, DLFAPA, DFCPA, FACPsych, FRSC

May 28th 2025

Psychiatry and the “Worst Movie Ever Made”

BySamuel R. Weber, MD,David C. Wall, PhD

October 23rd 2024

Latest CME

Video

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Sanjai Rao, MD, DFAPA; Dawn I. Velligan, PhD

In-Person Event

Southern Florida Psychiatry Conference

November 21-22, 2025

Register now!

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

In This Issue of Psychiatric Times: Vol 37, No 2

Articles in this issue

Newsletter

Related Content

“Porosity”: Connecting 2 Western Cultural Psychiatric Discourses in Tokyo by Way of Naples

Social Determinants of Health and Mental Health: Concepts and Practice of Growing Relevance

The Psychiatric Lens on Extraordinary Experiences: Improving Care Without Misdiagnosis

Social Psychiatry and Culturally Relevant Psychotherapy at the APA Annual Meeting

Psychiatry and the “Worst Movie Ever Made”

Latest CME

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Southern Florida Psychiatry Conference

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

FDA Approves Caplyta for Adjunctive Treatment of Major Depressive Disorder

The Spiritual Determinants of Health and Mental Health

Bridging the Categorical-Dimensional Divide: Exploring the PRiSM Diagnostic Instrument

Caplyta FDA Approval: Benefits for Patients, With Roger McIntyre, MD

Combination Therapy With TMS and Ketamine for Depression, Neuropathic Pain, and Substance Use Disorder: A Network-Based Approach